Shares of Concert Pharmaceuticals Inc. (CNCE) are up nearly 150% year-to-date compared to the modest 20% returned by the iShares NASDAQ Biotechnology Index (ETF) (IBB) during the same time frame.
from RTT - Biotech http://ift.tt/2CWqSZQ
via IFTTT
No comments:
Post a Comment